Form 4: Director Leslye G. Katz Increases Encompass Health Stake

Director Leslye G. Katz acquired 85 restricted stock units of Encompass Health Corp via dividend reinvestment.

Summary

• Director Leslye G. Katz was granted 85 restricted stock units (RSUs) on April 15, 2026.
• The acquisition resulted from the reinvestment of dividends paid on Encompass Health common stock.
• The total number of securities beneficially owned by the director following this transaction is 47,924 shares.
• The transaction was executed at a price of $0 per share as part of an existing RSU award agreement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on the company's fundamental outlook.

Positives

• Director maintains a significant long-term equity stake of 47,924 shares in the company.
• Automatic dividend reinvestment reflects ongoing alignment between director interests and shareholder returns.

Negatives

• None identified; this is a routine administrative transaction related to dividend payments.

Risks

• None identified; this filing pertains to routine equity compensation adjustments.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for corporate insiders and does not signal a change in company strategy or market outlook.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for non-employee director compensation and dividend reinvestment programs common among S&P 500 healthcare companies.

Stakeholder Impact

• Minimal impact; reflects standard director compensation mechanics.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Encompass Health, EHC, Form 4, Insider Trading, Director Ownership, Dividend Reinvestment